| Natco Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524816 |
NSE Symbol : NATCOPHARM |
P/E(TTM) : 11.80 |
|
ISIN Demat : INE987B01026 |
Div & Yield% : 0.61 |
EPS(TTM) : 83.75 |
|
Book Value(₹) : 461.80 |
Market Cap(₹Cr) : 17,701.43 |
Face Value(₹) : 2.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 528.80 | 1,264.30 | 1,192.70 | 1,157.40 | 407.60 | 1,292.60 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 528.80 | 1,264.30 | 1,192.70 | 1,157.40 | 407.60 | 1,292.60 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 55.30 | 93.30 | 59.60 | 62.10 | 168.00 | 51.40 |
| Total Income | 584.10 | 1,357.60 | 1,252.30 | 1,219.50 | 575.60 | 1,344.00 |
| Total Expenditure | 408.50 | 711.80 | 653.00 | 596.20 | 378.20 | 501.90 |
| PBIDT | 175.60 | 645.80 | 599.30 | 623.30 | 197.40 | 842.10 |
| Interest | 8.30 | 11.70 | 2.60 | 8.80 | 3.40 | 3.00 |
| PBDT | 167.30 | 634.10 | 596.70 | 614.50 | 194.00 | 839.10 |
| Depreciation | 42.10 | 48.10 | 53.80 | 93.70 | 43.70 | 42.20 |
| Tax | 26.20 | 130.60 | 106.00 | 99.40 | 27.90 | 147.80 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -7.90 | -45.50 | -27.20 | -6.70 | -2.50 | -12.00 |
| Reported Profit After Tax | 106.90 | 500.90 | 464.10 | 428.10 | 124.90 | 661.10 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 106.90 | 500.90 | 464.10 | 428.10 | 124.90 | 661.10 |
| EPS (Unit Curr.) | 5.97 | 27.97 | 25.91 | 23.90 | 6.97 | 36.91 |
| EPS (Adj) (Unit Curr.) | 5.97 | 27.97 | 25.91 | 23.90 | 6.97 | 36.91 |
| Calculated EPS (Unit Curr.) | 5.97 | 27.98 | 25.93 | 23.92 | 6.98 | 36.93 |
| Calculated EPS (Adj) (Unit Curr.) | 5.97 | 27.98 | 25.93 | 23.92 | 6.98 | 36.93 |
| Calculated EPS (Ann.) (Unit Curr.) | 23.89 | 111.93 | 103.71 | 95.66 | 27.91 | 147.73 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 23.89 | 111.93 | 103.71 | 95.66 | 27.91 | 147.73 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 75.00 | 75.00 | 100.00 | 0.00 | 75.00 | 75.00 |
| Equity | 35.80 | 35.80 | 35.80 | 35.80 | 35.80 | 35.80 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 33.21 | 51.08 | 50.25 | 53.85 | 48.43 | 65.15 |
| PBDTM(%) | 31.64 | 50.15 | 50.03 | 53.09 | 47.60 | 64.92 |
| PATM(%) | 20.22 | 39.62 | 38.91 | 36.99 | 30.64 | 51.14 |